Nephros, Inc. (NEPH)
Nephros Market Cap : 31.03M for March 16, 2026
Market Cap Chart
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
Market Cap Benchmarks
| Cerus Corp. | 345.91M |
| Abbott Laboratories | 191.06B |
| Accuray, Inc. | 49.48M |
| Alphatec Holdings, Inc. | 1.907B |
| Plus Therapeutics, Inc. | 46.50M |
Market Cap Related Metrics
| PE Ratio | 26.43 |
| PS Ratio | 1.697 |
| PEG Ratio | 0.0176 |
| Price to Book Value | 3.042 |
| Price to Free Cash Flow | 19.38 |
| Price | 2.92 |
| Earnings Yield | 3.78% |
| PEGY Ratio | 0.0176 |
| Operating PE Ratio | 27.82 |
| Normalized PE Ratio | 26.43 |